ОбзорГрафикПрофильОсновная статистикаФинансовые показателиНовости
Деривативы
TraderScreen

Grifols SA GRIFOLS ORD SHS CLASS .../  ES0171996087  /

London International
24.05.2024  18:36:52 Изменение - Объем сделки Бид9:06:30 Предложение9:06:30 Рыночная капитализация Дивидендная доходность Коэффициент Цена/Доход
9.190EUR - 64,479
Оборот: 338,526.545		 10.915Величина цены спроса: 3,000 11.405Величина цены предложения: 3,000 9.5 млрдEUR - 123.72
GlobeNewswire 31.07 GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HB...
GlobeNewswire 29.07 Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strength...
TeleTrader 08.07 Grifols family, Brookfield consider €5.5B takeover bid for Grifols
GlobeNewswire 01.07 Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Newsfile Corp 27.06 GRFS SHAREHOLDER ALERT: Johnson Fistel Announces Class Action Investigation of Grifols, S.A. for Pot...
GlobeNewswire 18.06 Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
GlobeNewswire 17.06 Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
GlobeNewswire 20.05 GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...
GlobeNewswire 18.04 Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire 04.04 Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire 31.03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 29.03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire 25.03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire 23.03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 22.03 Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investig...
GlobeNewswire 20.03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire 15.03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 01.03 GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) ...
GlobeNewswire 14.02 Grifols announces positive topline phase 3 fibrinogen clinical trial results
GlobeNewswire 12.02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman
GlobeNewswire 11.02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 08.02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman
GlobeNewswire 02.02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire 02.02 Grifols S.A.: Company Investigated by the Portnoy Law Firm
GlobeNewswire 01.02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman